Archive

ISC 2019 showcases great science

If you attend only one stroke conference each year, don’t miss ISC 2019, Feb. 6-8 in Honolulu!

During this 2-1/2-day meeting, you will be able to choose from more than 1,600 presentations (including the very latest in stroke trial results, provocative debates and illuminating invited talks) that emphasize basic, clinical and translation sciences as they evolve to a better understanding of stroke pathophysiology with the goal of developing more effective therapies.

In addition to all of this great science, you can take in other ISC audience favorites such as Game of Strokes, CED Talks (Cerebrovascular Education and Discovery), Crossfire Debates and ten joint international association sessions. New this year, we have added other program highlights including a Town Hall Forum that will focus on Women in Stroke; a Mock Courtroom Trial:  The Case of ESUS: Anti-Platelets versus Anti-Thrombin or Anti-Xa: What Is the Best “Anti” for My Patient?; and NIH Clinical and Applied Research Programs in Vascular Contributions to Cognitive Impairment and Dementia.

But don’t take our word for it. See what your peers have to say in this video.

Stroke in the Lab World: Cutting-Edge Topics in Experimental Stroke Research

This stimulating pre-conference symposium is designed to discuss emerging topics in basic and pre-clinical stroke studies and to synergize with the main conference, which has a substantial component concerning the clinical aspects of vascular diseases. While stroke is primarily considered a CNS event, peripheral systems have enormous influence in brain injury development and the recovery process.

In this full day symposium, leaders in the field will discuss how the peripheral gut system and the body’s metabolic status influence the pathophysiology of cerebrovascular diseases, including the role of peripheral immune cells in CNS injury and neuroimmune interactions in stroke. It will also address recently developed imaging techniques to visualize neuroinflammation. Additional highlights of this symposium include presentations by junior investigators who were selected to meet our mission of fostering young investigators to further advance the stroke field.

This Pre-Conference Symposium, to be held Tuesday, Feb. 5, is being held in conjunction with the International Society of Cerebral Blood Flow and Metabolism (ISCBFM). The ASA would like to thank them for their generous support of and educational contribution to Stroke in the Lab World: Cutting-Edge Topics in Experimental Stroke Research. The ASA would also like to thank the ISCBFM for their generous support of the travel grants to the Junior Investigators who will be presenting at Stroke in the Lab World: Cutting-Edge Topics in Experimental Stroke Research.

Learning Objectives:

After participating in this activity, participants will be able to:

  • Discuss the complex interaction between the gut and brain in vascular diseases
  • Relate the dichotomous role of microbiota in stroke
  • Demonstrate the regulatory role of metabolic function in innate host response
  • Determine the potential benefits of ketone bodies in stroke outcome
  • Explain the therapeutic utility of myeloid cells in neuroinflammation in stroke
  • Illustrate the role of monocyte-derived macrophage in functional recovery in stroke
  • Document imaging as a marker for early network organization
  • Assess the use of in vivo imaging and optogenetic tools for structural plasticity in stroke

 

Don’t miss these industry events

You’ll participate in an array of sessions, interactive training and debates at the AHA/ASA’s International Stroke Conference 2019 Feb. 4-6.

But there’s even more at ISC. Be sure to also check out Unofficial Satellite Events and Expert Theaters.

The events are independently organized by exhibitors, universities, nonprofits and industry supporters to provide prime opportunities to learn about the latest scientific advancements, and the theaters are settings to discover the newest products and services for stroke specialists.

Unofficial Satellite Events

Unofficial Satellite Events are not a part of the official International Stroke Conference planned by the ISC Program Committee.

Society of NeuroInterventional Surgery
https://snis.memberclicks.net/jcv2019reg#/
2-6 p.m. Feb. 4 / 8 a.m.-5 p.m. Feb. 5
Sheraton Waikiki
Sponsor: SNIS
Supported by: CV Section

Route to Severe Stroke Management: Diagnosis and Treatment of Large Hemispheric Infarction
7-9 p.m. Feb. 6
Prince Waikiki Hotel, Pi’lnaio Ballroom
Sponsor: Biogen
Supported by: Biogen

Current Controversies in Stroke: Stroke Care in the Real World
6:30-10 p.m. Feb. 6
Hilton Hawaiian Village, Waikiki Beach Resort, Tapa Ballroom 1-2
Sponsor: Medtronic
Supported by: Medtronic

Expert Theaters, Booth 152

These events are not part of the official International Stroke Conference 2019 as planned by the International Stroke Conference Program Committee. Complimentary lunch will be provided by the American Heart Association/American Stroke Association to the first 100 attendees.

Reversal of Novel Oral Anticoagulants in Patients Experiencing Life-Threatening Bleeds
12:10-12:40 p.m. Feb. 6
Sponsor: Portola Pharmaceuticals

To Be Announced
1-1:30 p.m. Feb. 6
Sponsor: VIZ

Personalized Medicine and Post-ESUS Risk Reduction Strategies
12:10-12:40 p.m. Feb. 7
Sponsor: Medtronic

 

State-of-the-Science Stroke Nursing Symposium 2019

The State-of-the-Science Stroke Nursing Symposium is a can’t-miss forum designed to provide cutting-edge information for nursing, rehabilitation and other healthcare professionals who treat patients and families in all phases of stroke care from prevention to treatment in the emergency department through rehabilitation. The symposium will update and inform the audience about nursing issues along the continuum of stroke care (primary and secondary prevention, ischemic and hemorrhagic stroke management, rehabilitation and program development).

The goal of the program is to share innovative best clinical practices that have been developed to optimize patient outcomes. An exciting plenary program and stimulating breakout sessions are planned to meet educational needs for nurses, rehabilitation and healthcare professionals at various skill levels.

Key takeaways of the nursing symposium include:

  • Explain practical approaches to treat acute ischemic stroke, such as NIHSS and nuances, ICU stroke care, stroke imaging and perfusion scanning, stroke etiology and acute stroke complications
  • Recognize the unexpected twists in the road during stroke recovery, such as sexuality post-stroke, fatigue and driving after stroke and returning to work and caregiver support.
  • Summarize various professional education topics, such as the latest clinically relevant topics and tips from top nurse experts; Boot Camp Training for stroke coordinators; and how to successfully disseminate stroke knowledge, including how to prepare an excellent abstract, outlining what the basic skills of a published author are and how to transform your presentation to publication
  • Describe advances in clinical research, practice and quality improvement, including addressing stroke center issues with quality improvement projects (facilitating timely transfers, optimal management of length of stay, preventing long and short-term readmissions); palliative care and stroke: caring for the whole patient and engaging families early; and using biologic markers to personalize treatment for stroke-related symptoms and outcomes including antibody profiling in stroke, bioenergetics for post-stroke fatigue, and fMRI in post-stroke depression
  • Demonstrate how to facilitate admission, progression and discharge for stroke, such as the nurse’s role in stroke care transitions, the benefits of coordinated stroke care post-hospitalization and infusing technology in rehabilitation and recovery.

Pre-Con I covers “Stroke in the Real World”

This day-long Pre-Conference Symposium of the International Stroke Conference takes place Tuesday, Feb. 5 and will provide the latest information for healthcare professionals caring for patients with, or at risk for stroke. This one-day symposium highlights scientific advances in cerebrovascular disease while emphasizing their application in the real world. The symposium informs the audience about issues along the full continuum of stroke care and covers varied topics of interest to healthcare providers working in the emergency department, hospitalist settings, primary care, general neurology, pharmacies, and other stroke care arenas.

This year’s symposium will focus on the rare causes of stroke including: identifying, distinguishing and a rheumatology perspective on CNS vasculitis; distinguishing vasculitis, vasospasm and atherosclerosis; mechanism of inherited small vessel ischemic lesions; neurocutaneous cause of stroke; endocarditis – treatment and indications for surgery; genetic collagen vasculopathies; interventions in FMD and moyamoya; MELAS; and stroke in the transgender patient. There will also be a series of challenging breakout sessions focusing on stroke in the cancer patient; stroke in pregnancy; and therapeutic challenges in treating infectious causes of Stroke including HIV, VZV, nematodes, tics, and fungal. Participants will also have the opportunity to have an informal lunch with the faculty where questions or challenging stroke cases may be discussed. (Please note you must register to attend the Pre-Conference Symposium.)

The learning objectives of this pre-conference include:

  • Discuss uncommon causes of stroke
  • Identify and differentiate CNS vasculitis
  • Propose treatment options for CNS vasculitis from a rheumatology perspective
  • Determine vasculitis, vasospasm and atherosclerosis
  • Define mechanisms of inherited small vessel ischemic lesions
  • Recognize neurocutaneous causes of stroke
  • Assess treatment for endocarditis including indications for surgery
  • Describe genetic collagen vasculopathies
  • Explain the perils and pitfalls in interventions in FMD and MoyaMoya
  • Describe MELAS from bench to bedside
  • Discuss stroke in the transgender patient
  • Manage stroke in the cancer patient
  • Recognize therapeutic challenges in treating infectious causes of stroke including HIV, VZV, nematodes, tics, and fungal
  • Document stroke in pregnancy

ISC 2019 is essential to your career

The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. From forming multiple, life-long collaborations with the best minds in the profession to hearing the latest big trial results to the exceptional education and science, if you are involved in the stroke medical profession, ISC is essential to your career.

This 2½-day conference features more than 1,600 compelling presentations in 21 categories that emphasize basic, clinical and translational sciences as they evolve toward a better understanding of stroke pathophysiology with the goal of developing more effective therapies.

This conference provides the opportunity to network with thousands of colleagues in the stroke field from around the world with wide-ranging expertise and experience.

This year will see the return of many favorite sessions including Game of Strokes; CED Talks (Cerebrovascular Education and Discovery); Crossfire Debates in the Closing Main Event; and 9 joint international association sessions. Just a few of the new additions to the program include the Town Hall Forum focusing on Women in Stroke; a Mock Courtroom Trial: The Case of ESUS: Anti-platelets vs Anti-thrombin or Anti-Xa: What Is the Best “Anti” for My Patient?; and NIH Clinical and Applied Research Programs in Vascular Contributions to Cognitive Impairment and Dementia (VCID) (Joint Government Agency Session).

Clinical Sessions focus on community risk factors; emergency care; acute neuroimaging; acute endovascular and acute nonendovascular treatment; diagnosis of stroke etiology; cerebral large artery disease; in-hospital treatment; clinical rehabilitation and recovery; and health services, quality improvement, and patient-centered outcomes.

Basic Science Sessions focus on vascular biology in health and disease; basic and preclinical neuroscience of stroke recovery; and experimental mechanisms and models. Further specialized topics include pediatric stroke; intracerebral hemorrhage; nursing; preventive strategies; vascular cognitive impairment; aneurysms; subarachnoid hemorrhage; neurocritical care; vascular malformations; and ongoing clinical trials.

Presentations on these topics attract a wide range of healthcare professionals and investigators including adult and pediatric neurologists; neurosurgeons; neuroradiologists and interventional radiologists; physiatrists; emergency medicine specialists; primary care physicians; hospitalists; nurses and nurse practitioners; rehabilitation specialists; physical, occupational, and speech therapists; pharmacists; and basic researchers spanning the fields of cerebrovascular function and disease.

Join us in Hawaii for ISC 2019

Dear Colleague:

Miguel Perez-Pinzon, PhD, FAHA
Chair of the International Stroke Conference 2019 Program Committee

This is a thrilling time in the field of cerebrovascular disease as the stroke landscape is evolving at an ever-increasing rate. Learn about all of the latest advances in stroke and receive the most compelling stroke education by being a part of the International Stroke Conference – connecting the world to stroke science.

The 2019 conference will take place Feb. 6-8 in stunning Honolulu, Hawaii. On behalf of the American Stroke Association, a division of the American Heart Association, and the Stroke Council Program Committee, we warmly welcome you to join us.

The program emphasizes basic, clinical and translational sciences as they evolve toward a more complete understanding of stroke pathophysiology with the overall goal of developing more effective prevention and treatment. Stroke systems of care, quality and outcomes are also key parts of the conference.

The International Stroke Conference 2019 provides unique opportunities to meet and network with colleagues from around the world with wide-ranging research interests and expertise in stroke prevention, diagnosis, treatment and rehabilitation. For 2019, we anticipate more than 4,500 professional attendees, as well as exhibitors displaying exciting, new stroke products and services. We are truly dedicated to the international nature of this conference with science, attendees, presenters and faculty coming from all corners of the world.

The 2019 program offers three separate pre-conference symposia: the State-of-the-Science Stroke Nursing Symposium; the ISC Pre-Conference Symposium I: Stroke in the Real World: In Search of the Big Kahuna: Rare Causes of Stroke, which will focus on rare causes of stroke; and the ISC Pre-Conference Symposium II: Stroke in the Lab World: Cutting-Edge Topics in Experimental Stroke Research, which will be held in conjunction with the International Society of Cerebral Blood Flow and Metabolism. The main days of the ISC include compelling invited symposia; rousing debates; provocative oral scientific abstract presentations; intriguing scientific abstract posters; and special lectures on recent advances and state-of-the-science technologies.

This premier conference is intended for adult and pediatric neurologists; neurosurgeons; neuroradiologists and interventional radiologists; physiatrists; endovascular specialists; emergency medicine specialists; primary care physicians; hospitalists; nurses and nurse practitioners; rehabilitation specialists; physical, occupational, and speech therapists; and pharmacists. Additionally, the ISC is just as much home for basic scientists, clinical scientists, stroke program coordinators, policymakers and public health officials who work in the stroke field.

Stimulating symposia, debates and abstract presentations will focus on numerous topics from 21 stroke-related categories. The latest results from major clinical trials will be presented at the meeting. Sessions in clinical categories will center on community risk factors; emergency care; acute neuroimaging; acute endovascular and acute nonendovascular treatment; diagnosis of stroke etiology; cerebral large artery disease; in-hospital treatment; clinical rehabilitation and recovery; and health services, quality improvement, and patient-centered outcomes.

Sessions in basic science categories focus on vascular biology in health and disease; basic and preclinical neuroscience of stroke recovery; and experimental mechanisms and models. Further specialized topics include pediatric stroke; intracerebral hemorrhage; nursing; preventive strategies; vascular cognitive impairment; aneurysms; subarachnoid hemorrhage; neurocritical care; vascular malformations; and ongoing clinical trials.

In addition to exceptional education and networking with thousands of cerebrovascular research and practice experts from around the globe, you will also have the opportunity to experience the glorious island of Oahu. It is truly all of Hawaii on one island — tropical playground and urban fantasy. Rich in Hawaiian culture, the island has outstanding resort areas, and features the electrifying city of Honolulu with cosmopolitan shopping, multi-ethnic cuisine and exhilarating entertainment.

The other side of Oahu is a stunning tropical island with breathtaking natural beauty and an abundance of recreational activities on land, in the ocean, and by air. Partake in one of the many outdoor activities, explore the rich Hawaiian history, or just enjoy one of the exquisite beaches. At night, you can enjoy the Hawaii Regional Cuisine, jazz bars and stylish nightclubs. Add a few days to your stay in order to explore everything the island has to offer and make this meeting a true experience.

Please join us for the International Stroke Conference 2019 in beautiful downtown Honolulu and be a part of this outstanding and illuminating experience. We look forward to seeing you in February.

ISC 2019 — Education. Inspiration. Illumination.

Pre-Conference Symposium I: There Will Be Blood

Your patient comes into the ER with a head trauma. Another presents with an intracranial hemorrhage due to hypertension. What are the best ways to manage and treat ICH? You can find out in Pre-Conference Symposium I of the AHA/ASA’s International Stroke Conference 2018.

“Stroke in the Real World: There Will Be Blood: Management and Treatment of ICH,” held on Jan. 23 in Room 151 at the Los Angeles Convention Center, will include presentations on:

  • Pre-hospital diagnosis and treatment
  • Emergency department stabilization and triage of the ICH patient
  • Understanding toxic clot constituents and cytotoxicity
  • A debate on minimally invasive surgery
  • How to investigate and image vascular lesions in ICH
  • Effects of size and ICH expansion
  • Amyloid angiopathy and microbleeds

Attendees also can participate in challenging breakout sessions and ask questions during an informal lunch with the faculty.

The symposium requires a separate fee to attend. Register now.

Symposium Schedule
9 a.m.
Welcome
Bruce Ovbiagele, MD, MSc, MAS, FAHA, Charleston, South Carolina

9:05 a.m.
“Scoop and Run: Pre-Hospital Diagnosis and Treatment of ICH”
Nerses Sanossian, MD, Los Angeles, California

9:20 a.m.
Q&A

9:30 a.m.
“The Golden Hour: ED Stabilization and Triage of the ICH Patient”
Opeolu Adeoye, MD, Cincinnati, Ohio

9:50 a.m.
Q&A

10 a.m.
“The Killing Fields: Toxic Clot Constituents and Cytotoxicity”
Guohua Xi, MD, Ann Arbor, Michigan

10:30 a.m.
Q&A

10:40 a.m.
“Double Indemnity: Surgery or Not? Minimally Invasive Surgery, Evidence and Debate” — Pro
Daniel F. Hanley, MD, FAHA, Baltimore, Maryland

10:55 a.m.
“Double Indemnity: Surgery or Not? Minimally Invasive Surgery, Evidence and Debate” — Con
Speaker TBD

11:10 a.m.
Q&A

11:20 a.m.
“Apocalypse Now: ICU Controversies: Where Is the Evidence?”
Navaz P. Karanjia, MD, San Diego, California

11:50 a.m.
Q&A

Noon-1 p.m.
Lunch

1 p.m.
“Lock, Stock and Two Barrels: Vascular Lesions in ICH? How to Investigate and Image”
Christian Stapf, MD, Montreal, Quebec, Canada

1:30 p.m.
Q&A

1:40 p.m.
“Larger Than Life: ICH Expansion and Size: Does the Size Matter?”
David Rodriguez-Luna, MD, PhD, Barcelona, Spain

2 p.m.
Q&A

2:10-2:55 p.m.
Concurrent IA (Room 502 A)
“The Ugly Truth: Practical Prognostication and Palliation: What Is the Evidence?”
Shouri Lahiri, MD, New York

Concurrent IB (Room 502 B)
“The Dark Knight: Complex Clinical Scenarios in ICH: When to Resume Anticoagulation”
Ashkan Shoamanesh, MD, Ancaster, Ontario, Canada

Concurrent IC (Room 515 A)
“Cloudy With a Chance of Meatballs: Role of Reversal Agents”

  • Role of Reversal Agents — Pro
    Patrick Lyden, MD, Los Angeles, California
  • Role of Reversal Agents — Con
    Dariush Dowlatshahi, MD, PhD, FRCPC, Ottawa, Ontario, Canada

3-3:45 p.m.
Concurrent IIA (Room 502 A)
“The Ugly Truth: Practical Prognostication and Palliation: What Is the Evidence?”
Shouri Lahiri, MD, New York

Concurrent IIB  (Room 502 B)
“The Dark Knight: Complex Clinical Scenarios in ICH: When to Resume Anticoagulation”
Ashkan Shoamanesh, MD, Ancaster, Ontario, Canada

Concurrent IIC (Room 515 A)
“Cloudy with a Chance of Meatballs: Role of Reversal Agents”

  • Role of Reversal Agents — Pro
    Patrick Lyden, MD, Los Angeles, California
  • Role of Reversal Agents — Con
    Dariush Dowlatshahi, MD, PhD, FRCPC, Ottawa, Ontario, Canada

4 p.m.
“Gorillas in the Mist: Congophilic Amyloid Angiopathy and Microbleeds: Diagnosis, Prognosis and Implications for Treatment”
Branko N. Huisa, MD, San Diego, California

4:30 p.m.
Q&A

4:40 p.m.
“Kramer vs. Kramer Debate: ‘Sweet Spot’ for Blood Pressure after ICH” — Pro Intense Therapy
Craig Anderson, MD, PhD, Sydney NSW, Australia

4:50 p.m.
“Kramer vs. Kramer Debate: ‘Sweet Spot’ for Blood Pressure after ICH” — Pro Moderate Therapy
Ken S. Butcher, MD, PhD, FRCP(C), Parkville Melbourne, Australia

5 p.m.
Q&A

5:05 p.m.
Gone in 60 Seconds: Closing Remarks
Bruce Ovbiagele, MD, MSc, MAS, FAHA, Charleston, South Carolina

Pre-Conference Symposium II: From Beside-to-Bench and Back Again

After four decades of investigating mechanisms involved in ischemic brain injury, we have yet to develop an FDA-approved neuroprotective agent. Is reversing translational research the answer?

You can explore this new paradigm in Pre-Conference Symposium II at the AHA/ASA’s International Stroke Conference 2018.

“Stroke in the Lab World: Reversing Stroke Translational Research — Bedside-to-Bench and Back Again” will be held on Jan. 23 in Theater 411 at the Los Angeles Convention Center. It will feature leading researchers who have successfully achieved reverse translation, starting with human samples and applying cutting-edge big data techniques to identify genes/proteins of relevance.

Attendees will further explore examples of next steps needed to understand molecular mechanisms implicated by the genes/proteins identified by these new -omic techniques.

There is a separate fee to attend. Register here.

Symposium Schedule
1 p.m.
“Failure of Traditional Forward Translation: The Case of Neuroprotection”
Jin-Moo Lee, MD, PhD, St. Louis, Missouri

1:15 p.m.
“Genomics Approach to Reverse Translation”
Daniel Woo, MD, Cincinnati, Ohio

1:55 p.m.
“Probing Biofluids to Understand Disease Pathogenesis: A Transcriptomics Approach”
Frank Ray Sharp, MD, Sacramento, California

2:35-2:45 p.m.
Break

2:45 p.m.
“Integrating Big Data Across the Omics: A Systems Biology Approach”
Philip De Jager, MD, New York

3:25 p.m.
“Bedside-to-Bench-to-Drug Target”
Martin Dichgans, MD, Munich, Germany

4:05 p.m.
“Harvesting Human Cells to Develop ‘Disease-in-a-Dish’”
Adam Engler, PhD, La Jolla, California

4:45 p.m.
Q&A

Don’t miss these industry events

You’ll participate in an array of sessions, interactive training and debates at the AHA/ASA’s International Stroke Conference 2018 on Jan. 24-26 at the Los Angeles Convention Center.

But there’s even more at ISC. Be sure to also check out Unofficial Satellite Events and Expert Theaters.

The events are independently organized by exhibitors, universities, nonprofits and industry supporters to provide prime opportunities to learn about the latest scientific advancements, and the theaters are settings to discover the newest products and services for stroke specialists.

Unofficial Satellite Events

Unofficial Satellite Events are not a part of the official International Stroke Conference planned by the ISC Program Committee.

Monday, Jan. 22
Time: 8 a.m.-5 p.m.
Title: Joint Cerebrovascular Section Annual Meeting
Location: Millennium Biltmore Hotel
Sponsored and supported by SNIS

Wednesday, Jan. 24
Time: 7-9 p.m.
Title: PFO Closure – Addressing the Unmet Need for Reducing the Risk of Recurrent Ischemic Stroke
Location: Sheraton Grand Los Angeles, Wiltern Room
Sponsored and supported by Abbott

Expert Theaters

Sessions in the Expert Theaters feature new stroke products and therapeutic treatments presented by industry supporters. The ASA will provide a complimentary lunch.

Wednesday, Jan. 24
Time: 12:10-12:40 p.m.
Title: Journey to ENRICH: The Evolutionary Trend Supporting Early Surgical Intervention for Intracerebral Hemorrhage
Speakers: Dr. Gustavo Pradilla, assistant professor of neurosurgery, Emory University School of Medicine, Atlanta, Georgia, and chief of neurosurgery service, Marcus Stroke & Neuroscience Center, Grady Health System, Atlanta, Georgia; Dr. Mark Bain, director of the Cerebrovascular Neurosurgery Fellowship Program, The Cleveland Clinic, Cleveland, Ohio
Supported by NICO Corp.

Thursday, Jan. 25
Time: 12:10-12:40 p.m.
Title: Cryptogenic Stroke — The Missing Linq
Speaker: Robert Felberg, MD, medical director, Overlook Hospital, Summit, New Jersey
Supported by Medtronic

Top